UBA1 loss-of-function mutations in VEXAS result in distinct phenotypes not observed in model organisms, including inflammation, cytopenias, thrombotic tendencies, clonality, and blood cancer associations [1]. This evidence concerns the gene UBA1 and hematopoietic and lymphoid system neoplasm.